Related Experiment Video
Updated: Dec 11, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
COVID-19 and type 1 diabetes: dealing with the difficult duo
Subhankar Chowdhury1, Soumik Goswami2
1Department of Endocrinology and Metabolism, IPGME&R and SSKM Hospital, Kolkata, India.
Insights
This review addresses the unique challenges of Coronavirus disease 2019 (COVID-19) in patients with type 1 diabetes (T1D). More research is needed to fully understand and manage this complex interaction.
Area of Science:
- Endocrinology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) poses significant health risks, especially for individuals with diabetes.
- Existing research on COVID-19 and diabetes primarily focuses on type 2 diabetes (T2D).
- Type 1 diabetes (T1D) patients face distinct challenges during the COVID-19 pandemic.
Purpose of the Study:
- To review existing literature, guidelines, and websites concerning type 1 diabetes and COVID-19.
- To address key questions and concerns for T1D patients during the pandemic.
- To consolidate current evidence on the intersection of T1D and COVID-19.
Main Methods:
- Systematic literature search of the PubMed database up to May 31, 2020.
- Inclusion of all articles related to type 1 diabetes and COVID-19.
- Narrative review methodology to synthesize findings.
Main Results:
- Identified 18 relevant articles discussing T1D and COVID-19.
- Evidence covers COVID-19 risk in T1D, impact on T1D development, outcomes, and management.
- Findings highlight specific risks and management considerations for T1D patients with COVID-19.
Conclusions:
- Managing COVID-19 in patients with type 1 diabetes presents unique difficulties.
- Current evidence provides some insights but is insufficient for comprehensive management.
- Further research is crucial to address the complexities of COVID-19 in type 1 diabetes.
Background:
Coronavirus disease 2019 (COVID-19) has aroused global health concerns, particularly in relation to diabetes where it has been associated with poorer outcomes. The bulk of the evolving evidence in diabetes and COVID-19 relates to type 2 diabetes (T2D). Since there are a significant number of patients with type 1 diabetes (T1D) with unique concerns and challenges during the ongoing COVID-19 pandemic, we reviewed existing literature, relevant websites, and related guidelines to form this narrative review to help address key questions in this area.
Methods:
We systematically searched the PubMed database up to May 31, 2020, and retrieved all the articles published on T1D and COVID-19.
Results:
We found 18 relevant articles, each of which carried a part of the evidence regarding the risk of contracting COVID-19 in patients with T1D, effect of COVID-19 on development of T1D, outcomes in T1D with COVID-19, and special management issues in T1D in the light of COVID-19. These have been documented in the present review.
Conclusion:
COVID-19 with T1D presents special challenges. While the available evidence does shed some light, we need more evidence to deal with this difficult duo.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

